Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Shares Outstanding (Weighted Average) (2022 - 2023)

Bluejay Diagnostics' Shares Outstanding (Weighted Average) history spans 2 years, with the latest figure at $137871.0 for Q3 2023.

  • For Q3 2023, Shares Outstanding (Weighted Average) fell 86.32% year-over-year to $137871.0; the TTM value through Sep 2023 reached $137871.0, down 86.32%, while the annual FY2022 figure was $1.0 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2023 was $137871.0 at Bluejay Diagnostics, up from $127608.0 in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $20.1 million in Q1 2022 and bottomed at $127608.0 in Q2 2023.